Single-Short Partial Reprogramming of the Endothelial Cells Decreases Blood Pressure via Attenuation of EndMT in Hypertensive Mice
Circulation Research · 2025
DOI: 10.1161/circresaha.124.324909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, 2025. Verfasst von Laena Pernomian und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Anatomy, Cardiovascular Translational Research Center (L.P., E.W.W., T.J.C., M.T.F., C.G.M., C.F.W.), School of Medici…. Hauptthemen laut MEDLINE: Hypertension, Endothelial Cells, Blood Pressure, Cellular Reprogramming. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Small artery remodeling and endothelial dysfunction are hallmarks of hypertension. Evidence supports a likely causal association between cardiovascular diseases and endothelial-to-mesenchymal transition (EndMT), a cellular transdifferentiation process in which endothelial cells (ECs) partially lose their identity and acquire mesenchymal phenotypes. EC reprogramming represents an innovative strategy in regenerative medicine to prevent deleterious effects induced by cardiovascular diseases. METHODS: Using partial reprogramming of ECs, via overexpression of Oct-3/4-Sox-2-Klf-4 (OSK) transcription factors, we aimed to bring ECs back to a youthful phenotype in hypertension. Primary ECs were infected with lentiviral vectors (LVs) containing the specific EC promoter Cdh5 (cadherin-5) and the reporter EGFP (enhanced green fluorescent protein) with empty vector (LV control) or LV with Oct-3/4-Sox-2-Klf-4. Confocal microscopy and Western blotting analysis were used to confirm OSK overexpression. Cellular migration, senescence, and apoptosis were evaluated. Human aortic ECs from normotensive patients and patients with hypertension were analyzed after OSK treatments for eNOS (endothelial nitric oxide synthase), nitric oxide (NO), and genetic profile. Male and female normotensive (BPN/3J or blood pressure normal mouse strain) and hypertensive (BPH/2J or blood pressure high mouse strain) mice were treated with LV control or LV with Oct-3/4-Sox-2-Klf-4 and evaluated 10 days post-infection. The blood pressure, cardiac function, vascular reactivity of small arteries, and EndMT inhibition were analyzed. RESULTS: OSK overexpression induced partial EC reprogramming in vitro, and these cells had lower migratory capability. OSK treatment of BPH/2J mice reduced blood pressure and resistance arteries hypercontractility, via the attenuation of endothelial-to-mesenchymal transition and elastin breaks. EGFP was detected in vivo in the prefrontal cortex. OSK-treated hypertensive human aortic ECs showed high eNOS activation and NO production, with low reactive oxygen species (ROS) formation. Single-cell RNA analysis showed that OSK alleviated EC senescence and EndMT, restoring their phenotypes in human aortic ECs from patients with hypertension. CONCLUSIONS: Overall, these data indicate that OSK treatment and EC reprogramming can decrease blood pressure and reverse hypertension–induced vascular damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Anatomy, Cardiovascular Translational Research Center (L.P., E.W.W., T.J.C., M.T.F., C.G.M., C.F.W.), School of Medicine Columbia, University of South Carolina.
- Department of Cell Biology and Anatomy (L.P., E.W.W., V.N., T.J.C., M.T.F., C.G.M., W.T., C.F.W.), School of Medicine Columbia, University of South Carolina.
- Department of Pathology, Microbiology and Immunology (A.D.M., J.L.K.), School of Medicine Columbia, University of South Carolina.
- Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, AL (A.V.A., V.C.B.).
- Department of Biomedical Engineering Program, University of South Carolina, Columbia (K.G., T.S., C.G.M., C.F.W.).
- Department of Genetics, Paul F. Glenn Center for Biology of Aging Research, Blavatnik Institute, Harvard Medical School, Boston, MA (D.A.S.).
ORCID-Profile: Laena Pernomian, Vi Nguyen, Ahmed D Mohammed, Andrew V Aitken, Vinicia Campana Biancardi, David A Sinclair, Cameron G McCarthy, Yunguan Wang, Wenbin Tan, Camilla Ferreira Wenceslau
Förderung
- American Heart Association-American Stroke Association
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIH HHS
- NIAMS NIH HHS
- NIA NIH HHS
Zitieren
APA
Pernomian, L., Waigi, E. W., Nguyen, V., Mohammed, A. D., Costa, T. J., Fontes, M. T., Kubinak, J. L., Aitken, A. V., Biancardi, V. C., Gleason, K., Shazly, T., Sinclair, D. A., McCarthy, C. G., Wang, Y., Tan, W., & Wenceslau, C. F. (2025). Single-Short Partial Reprogramming of the Endothelial Cells Decreases Blood Pressure via Attenuation of EndMT in Hypertensive Mice. Circulation Research. https://doi.org/10.1161/circresaha.124.324909
Vancouver
Pernomian L, Waigi EW, Nguyen V, Mohammed AD, Costa TJ, Fontes MT, et al. Single-Short Partial Reprogramming of the Endothelial Cells Decreases Blood Pressure via Attenuation of EndMT in Hypertensive Mice. Circulation Research. 2025. doi:10.1161/circresaha.124.324909
BibTeX
@article{Pernomian2025,
author = {Pernomian, Laena and Waigi, Emily W and Nguyen, Vi and Mohammed, Ahmed D and Costa, Tiago J and Fontes, Milene T and Kubinak, Jason L and Aitken, Andrew V and Biancardi, Vinicia Campana and Gleason, Kamryn and Shazly, Tarek and Sinclair, David A and McCarthy, Cameron G and Wang, Yunguan and Tan, Wenbin and Wenceslau, Camilla Ferreira},
title = {Single-Short Partial Reprogramming of the Endothelial Cells Decreases Blood Pressure via Attenuation of EndMT in Hypertensive Mice},
journal = {Circulation Research},
year = {2025},
doi = {10.1161/circresaha.124.324909}
}
EUVIMED